Skip to main content

Table 2 General characteristics of bid-winning antihypertensive drugs

From: The impact of “4 + 7” volume-based drug procurement on the volume, expenditures, and daily costs of antihypertensive drugs in Shenzhen, China: an interrupted time series analysis

Generic name Dosage form Specifications Bid-winning enterprises Time to market Bid-winning prices
(CNY per pill)
Prices before the policy
(CNY per pill)
Price drop (%)
Irbesartan tablet 75 mg Zhejiang Huahai Pharmaceutical Co., Ltd. Dec. 2017 0.20 0.66 -69.41
Amlodipine tablet 5 mg Zhejiang Jingxin Pharmaceutical Co.,Ltd. Nov. 2018 0.15 - -
Fosinopril tablet 10 mg Sino-American Shanghai Squibb Pharmaceuticals Ltd.* Dec. 2017 0.84 2.79 -69.82
Irbesartan hydrochlorothiazide tablet 150 mg + 12.5 mg Zhejiang Huahai Pharmaceutical Co., Ltd. Dec. 2017 1.09 3.72 -70.71
Lisinopril tablet 10 mg Zhejiang Huahai Pharmaceutical Co., Ltd. Dec. 2017 0.23 1.33 -82.66
Losartan tablet 50 mg Zhejiang Huahai Pharmaceutical Co., Ltd. Dec. 2017 1.05 2.64 -60.27
Enalapril tablet 5 mg Yangtze River Pharmaceutical Group Co.,Ltd. Apr. 2018 0.56 1.88 -70.33
  1. Note. * original drug